Anil K Chauhan Selected Research

ferric chloride

12/2020	Targeting myeloid-cell specific integrin α9β1 inhibits arterial thrombosis in mice.
4/2015	Endothelial PPAR-γ protects against vascular thrombosis by downregulating P-selectin expression.
5/2013	Red blood cells mediate the onset of thrombosis in the ferric chloride murine model.
5/2009	The distal carboxyl-terminal domains of ADAMTS13 are required for regulation of in vivo thrombus formation.
2/2008	Prothrombotic effects of fibronectin isoforms containing the EDA domain.
3/2007	von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anil K Chauhan Research Topics

Disease

28	Thrombosis (Thrombus) 01/2021 - 03/2006
14	Stroke (Strokes) 01/2022 - 12/2007
14	Inflammation (Inflammations) 01/2022 - 07/2006
9	Infarction (Infarctions) 01/2022 - 12/2007
8	Atherosclerosis 01/2022 - 09/2008
7	Ischemic Stroke 01/2022 - 06/2009
6	Reperfusion Injury 01/2019 - 05/2012
6	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 09/2014 - 09/2004
5	Hyperplasia 01/2021 - 12/2015
5	Vascular System Injuries 01/2021 - 02/2008
4	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021 - 01/2011
4	Neoplasms (Cancer) 01/2021 - 09/2008
4	Arthritis (Polyarthritis) 09/2014 - 09/2004
4	Thrombotic Thrombocytopenic Purpura 01/2010 - 10/2005
3	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2017
3	Carotid Artery Thrombosis 01/2020 - 05/2015
3	Ischemia 01/2020 - 01/2018
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 03/2012
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2018 - 12/2007
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2017 - 11/2011
3	Brain Ischemia (Cerebral Ischemia) 01/2016 - 05/2012
2	Vascular Remodeling 01/2022 - 01/2021
2	Transient Ischemic Attack 05/2018 - 12/2015
2	Vascular Diseases (Vascular Disease) 12/2015 - 06/2009
2	Atherosclerotic Plaque (Atheroma) 11/2015 - 03/2012
2	Brain Injuries (Brain Injury) 05/2012 - 10/2009
2	Hyperhomocysteinemia 03/2012 - 01/2006
2	Rheumatoid Arthritis 03/2011 - 09/2004
2	Thrombocytopenia (Thrombopenia) 05/2009 - 04/2008
1	Glaucoma 05/2022
1	Ganglion Cysts (Ganglion) 05/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022
1	Proteinuria 10/2021
1	Thrombotic Microangiopathies 10/2021
1	Atypical Hemolytic Uremic Syndrome 10/2021
1	Genomic Instability 01/2021

Drug/Important Bio-Agent (IBA)

14	Fibronectins (Fibronectin)IBA 01/2021 - 06/2006
12	von Willebrand FactorIBA 01/2018 - 03/2007
10	Apolipoproteins E (ApoE)IBA 01/2020 - 09/2008
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2009
7	Toll-Like Receptor 4IBA 05/2022 - 05/2012
7	EnzymesIBA 01/2022 - 10/2009
7	AntibodiesIBA 01/2022 - 09/2004
6	LigandsIBA 05/2022 - 02/2008
6	ferric chlorideIBA 12/2020 - 03/2007
6	human extra domain A fibronectinIBA 01/2020 - 05/2012
6	ApolipoproteinsIBA 01/2020 - 11/2015
5	IntegrinsIBA 01/2022 - 01/2016
5	FibrinIBA 01/2020 - 12/2015
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 11/2015
4	Protein Isoforms (Isoforms)IBA 05/2022 - 05/2012
4	Fibrinogen (Factor I)FDA Link 01/2022 - 03/2011
4	Pyruvate KinaseIBA 01/2022 - 01/2021
4	Phosphotransferases (Kinase)IBA 10/2021 - 12/2015
4	InterleukinsIBA 01/2019 - 11/2015
4	Metalloproteases (Metalloproteinases)IBA 01/2018 - 09/2008
4	thiamine triphosphorate (TTP)IBA 01/2010 - 10/2005
3	Complement System Proteins (Complement)IBA 10/2021 - 11/2011
3	ThrombospondinsIBA 01/2018 - 09/2008
3	DisintegrinsIBA 01/2018 - 09/2008
3	Antigen-Antibody Complex (Immune Complex)IBA 01/2017 - 07/2009
3	estropipate (Ogen)FDA LinkGeneric 01/2017 - 12/2015
3	P-SelectinIBA 04/2015 - 12/2007
3	Rheumatoid FactorIBA 09/2014 - 09/2004
3	cyclic citrullinated peptideIBA 09/2014 - 09/2004
3	Glycoproteins (Glycoprotein)IBA 01/2011 - 02/2008
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 01/2019
2	Peptides (Polypeptides)IBA 01/2022 - 09/2004
2	Dynamins (Dynamin)IBA 01/2020 - 01/2018
2	Superoxides (Superoxide)IBA 01/2020 - 01/2018
2	AntigensIBA 10/2018 - 01/2017
2	AntioxidantsIBA 05/2018 - 03/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2018 - 09/2008
2	Methionine (L-Methionine)FDA Link 01/2016 - 12/2015
2	Anti-Citrullinated Protein AntibodiesIBA 09/2014 - 09/2004
2	Phosphopyruvate Hydratase (Enolase)IBA 09/2014 - 03/2011
2	Immunoglobulin M (IgM)IBA 09/2014 - 03/2011
2	HomocysteineIBA 03/2012 - 01/2006
2	Factor VIII (Coagulation Factor VIII)IBA 01/2011 - 03/2007
2	ADAMTS13 ProteinIBA 10/2009 - 10/2005
2	Shiga Toxin (Shigella Toxin)IBA 04/2008 - 10/2005
2	adhesion receptorIBA 12/2007 - 03/2007
1	Messenger RNA (mRNA)IBA 05/2022
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2022
1	CytokinesIBA 01/2022
1	Diacylglycerol KinaseIBA 10/2021
1	LipidsIBA 10/2021
1	Dinoprostone (PGE2)FDA Link 10/2021
1	Chemokine ReceptorsIBA 10/2021
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 10/2021
1	UbiquitinIBA 01/2021
1	Valosin Containing ProteinIBA 01/2021
1	MineralocorticoidsIBA 01/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2021

Therapy/Procedure

7	Lasers (Laser) 01/2022 - 12/2007
6	Therapeutics 01/2022 - 03/2012
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2016 - 05/2015
3	Ligation 12/2015 - 03/2012
2	Thrombectomy 01/2020 - 05/2018